Vitamin K1 As A Potential Molecule For Reducing Single-Walled Carbon Nanotubes-Stimulated α-Synuclein Structural Changes And Cytotoxicity

References

• Butnaru D, Chapman J. The impact of self-replicating proteins on inflammation, autoimmunity and neurodegeneration—an untraveled path. Autoimmun Rev. 2019. doi:10.1016/j.autrev.2018.09.009
   PubMedGoogle Scholar
• Mohseni-Dargah M, Akbari-Birgani S, Madadi Z, Saghatchi F, Kaboudin B. Carbon nanotube-delivered iC9 suicide gene therapy for killing breast cancer cells in vitro. Nanomedicine 2019;14(8):1033–1047.
   Google Scholar
• Tagmatarchis N, Prato M. Functionalization of carbon nanotubes via 1, 3-dipolar cycloadditions. J Mater Chem. 2004;14(4):437–439. doi:10.1039/b314039c
   Web of Science ®Google Scholar
• Ali-Boucetta H, Kostarelos K. Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation. Adv Drug Del Rev. 2013;65(15):2111–2119. doi:10.1016/j.addr.2013.10.004
   PubMed Web of Science ®Google Scholar
• Zhao X, Lu D, Hao F, Liu R. Exploring the diameter and surface dependent conformational changes in carbon nanotube-protein corona and the related cytotoxicity. J Hazard Mater. 2015;292:98–107. doi:10.1016/j.jhazmat.2015.03.02325797928
   PubMed Web of Science ®Google Scholar
• Zhao X, Hao F, Lu D, Liu W, Zhou Q, Jiang G. Influence of the surface functional group density on the carbon-nanotube-induced α-chymotrypsin structure and activity alterations. ACS Appl Mater Interfaces. 2015;7(33):18880–18890. doi:10.1021/acsami.5b0589526248557
   PubMed Web of Science ®Google Scholar
• Bussy C, Al-Jamal KT, Boczkowski J, et al. Microglia determine brain region-specific neurotoxic responses to chemically functionalized carbon nanotubes. ACS Nano. 2015;9(8):7815–7830. doi:10.1021/acsnano.5b0235826043308
   PubMedGoogle Scholar
• Migliore L, Uboldi C, Di Bucchianico S, Coppedè F. Nanomaterials and neurodegeneration. Environ Mol Mutagen. 2015;56(2):149–170. doi:10.1002/em.2193125627719
   PubMedGoogle Scholar
• Costa PM, Bourgognon M, Wang JT, Al-Jamal KT. Functionalised carbon nanotubes: from intracellular uptake and cell-related toxicity to systemic brain delivery. J Control Release. 2016;241:200–219. doi:10.1016/j.jconrel.2016.09.03327693751
   PubMed Web of Science ®Google Scholar
• Kafa H, Wang JT-W, Rubio N, et al. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood–brain barrier in vitro and in vivo. J Control Release. 2016;225:217–225. doi:10.1016/j.jconrel.2016.01.03126809004
   PubMed Web of Science ®Google Scholar
• Luo J, Wärmländer SKTS, Yu C-H, Muhammad K, Gräslund A, Pieter Abrahams J. The Aβ peptide forms non-amyloid fibrils in the presence of carbon nanotubes. Nanoscale. 2014;6(12):6720–6726. doi:10.1039/c4nr00291a24820873
   PubMedGoogle Scholar
• Park M, Park J, Lee J, Ju S-Y. Scaling of binding affinities and cooperativities of surfactants on carbon nanotubes. Carbon. 2018;139:427–436. doi:10.1016/j.carbon.2018.07.003
   Web of Science ®Google Scholar
• Allegri M, Perivoliotis DK, Bianchi MG, et al. Toxicity determinants of multi-walled carbon nanotubes: the relationship between functionalization and agglomeration. Toxicol Rep. 2016;3:230–243. doi:10.1016/j.toxrep.2016.01.01128959543
   PubMed Web of Science ®Google Scholar
• Zeinabad HA, Zarrabian A, Saboury AA, Alizadeh AM, Falahati M. Interaction of single and multi wall carbon nanotubes with the biological systems: tau protein and PC12 cells as targets. Sci Rep. 2016;6:26508–26518. doi:10.1038/srep2650827216374
   PubMed Web of Science ®Google Scholar
• Li C, Mezzenga R. The interplay between carbon nanomaterials and amyloid fibrils in bio-nanotechnology. Nanoscale. 2013;5(14):6207–6218. doi:10.1039/c3nr01644g23744243
   PubMedGoogle Scholar
• Liu F, Wang W, Sang J, Jia L, Lu F. Hydroxylated single-walled carbon nanotubes inhibit aβ42 fibrillogenesis, disaggregate mature fibrils, and protect against Aβ42-induced cytotoxicity. ACS Chem Neurosci. 2019;10(1):588–598. doi:10.1021/acschemneuro.8b0044130335950
   PubMed Web of Science ®Google Scholar
• Marques O, Outeiro TF. Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis. 2012;3:350–360. doi:10.1038/cddis.2012.94
   PubMed Web of Science ®Google Scholar
• Wales P, Pinho R, Lázaro DF, Outeiro TF. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration. J Parkinsons Dis. 2013;3(4):415–459. doi:10.3233/JPD-13021624270242
   PubMedGoogle Scholar
• Valdinocci D, Radford RAW, Siow SM, Chung RS, Pountney DL. Potential modes of intercellular α-synuclein transmission. Int J Mol Sci. 2017;18(2):469–480. doi:10.3390/ijms18020469
   PubMedGoogle Scholar
• Book A, Guella I, Candido T, et al. A meta-analysis of α-Synuclein multiplication in familial parkinsonism. Front Neurol. 2018;9:1–10. doi:10.3389/fneur.2018.0000129403429
   PubMedGoogle Scholar
• Brundin P, Dave KD, Kordower JH. Therapeutic approaches to target alpha-synuclein pathology. Exp Neurol. 2017;298:225–235. doi:10.1016/j.expneurol.2017.10.00328987463
   PubMed Web of Science ®Google Scholar
• Alarcón-Arís D, Recasens A, Galofré M, et al. Selective α-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for parkinson’s disease. Mol Ther. 2018;26(2):550–567. doi:10.1016/j.ymthe.2017.11.01529273501
   PubMed Web of Science ®Google Scholar
• Pujols J, Peña-Díaz S, Lázaro DF, et al. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc Natl Acad Sci. 2018;115(41):10481–10486. doi:10.1073/pnas.180419811530249646
   PubMed Web of Science ®Google Scholar
• Li J, Zhu M, Rajamani S, Uversky VN, Fink AL, Inhibits R. α-synuclein fibrillation and disaggregates fibrils. Chem Biol. 2004;11(11):1513–1521. doi:10.1016/j.chembiol.2004.08.02515556002
   PubMedGoogle Scholar
• Li H-T, Lin D-H, Luo X-Y, et al. Inhibition of α-synuclein fibrillization by dopamine analogs via reaction with the amino groups of α-synuclein. Febs J. 2005;272(14):3661–3672. doi:10.1111/j.1742-4658.2005.04792.x16008565
   PubMedGoogle Scholar
• Zhu M, Han S, Fink AL. Oxidized quercetin inhibits α-synuclein fibrillization. Biochimi Et Biophys Acta. 2013;1830(4):2872–2881. doi:10.1016/j.bbagen.2012.12.027
   PubMed Web of Science ®Google Scholar
• da Silva FL, Coelho Cerqueira E, de Freitas MS, Gonçalves DL, Costa LT, Follmer C. Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein. Neurochem Int. 2013;62(1):103–112. doi:10.1016/j.neuint.2012.10.00123064431
   PubMedGoogle Scholar
• Ardah MT, Paleologou KE, Lv G, et al. Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity. Front Aging Neurosci. 2014;6(197):1–10. doi:10.3389/fnagi.2014.0000124478697
   PubMedGoogle Scholar
• McGlinchey RP, Lee JC. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein. Proc Natl Acad Sci. 2015;112(30):9322–9327. doi:10.1073/pnas.150093711226170293
   PubMed Web of Science ®Google Scholar
• Jha NN, Ghosh D, Das S, et al. Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity. Sci Rep. 2016;6:28511–28520. doi:10.1038/srep2851127338805
   PubMed Web of Science ®Google Scholar
• Alam P, Chaturvedi SK, Siddiqi MK, et al. Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases. Sci Rep. 2016;6:26759–26765. doi:10.1038/srep2675927230476
   PubMed Web of Science ®Google Scholar
• Hadden MK, Hill SA, Davenport J, Matts RL, Blagg BS. Synthesis and evaluation of Hsp90 inhibitors that contain the 1, 4-naphthoquinone scaffold. Biorg Med Chem. 2009;17(2):634–640. doi:10.1016/j.bmc.2008.11.064
   PubMed Web of Science ®Google Scholar
• Cerqueira EC, Netz PA, Diniz C, do Canto VP, Follmer C. Molecular insights into human monoamine oxidase (MAO) inhibition by 1, 4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO. Biorg Med Chem. 2011;19(24):7416–7424. doi:10.1016/j.bmc.2011.10.049
   PubMed Web of Science ®Google Scholar
• Ritchie DW, Venkatraman V. Ultra-fast FFT protein docking on graphics processors. Bioinformatics. 2010;26(19):2398–2405. doi:10.1093/bioinformatics/btq44420685958
   PubMed Web of Science ®Google Scholar
• Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012;4(1):17–25. doi:10.1186/1758-2946-4-1722889332
   PubMed Web of Science ®Google Scholar
• Mayo SL, Olafson BD, Goddard WA. Dreiding—A generic force-field for molecular simulations. J Phys Chem. 1990;94:8897–8909. doi:10.1021/j100389a010
   Web of Science ®Google Scholar
• Mahdavimehr M, Meratan AA, Ghobeh M, Ghasemi A, Saboury AA, Nemat-Gorgani M. Inhibition of HEWL fibril formation by taxifolin: mechanism of action. PLoS One. 2017;12(11):0187841–0187845. doi:10.1371/journal.pone.0187841
   Web of Science ®Google Scholar
• Breydo L, Wu JW, Uversky VN. α-Synuclein misfolding and Parkinson’s disease. Biochim Biophys Acta Mol Basis Dis. 2012;1822(2):261–285. doi:10.1016/j.bbadis.2011.10.002
   PubMed Web of Science ®Google Scholar
• Wan OW, Chung KK. The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson’s disease. PLoS One. 2012;7(6):38545–38554. doi:10.1371/journal.pone.0038545
   Web of Science ®Google Scholar
• Cavallo D, Fanizza C, Ursini CL, et al. Multi-walled carbon nanotubes induce cytotoxicity and genotoxicity in human lung epithelial cells. J Appl Toxicol. 2012;32(6):454–464. doi:10.1002/jat.271122271384
   PubMed Web of Science ®Google Scholar
• Avti PK, Caparelli ED, Sitharaman B. Cytotoxicity, cytocompatibility, cell-labeling efficiency, and in vitro cellular magnetic resonance imaging of gadolinium-catalyzed single-walled carbon nanotubes. J Biomed Mater Res A. 2013;101(12):3580–3591. doi:10.1002/jbm.a.3464323686792
   PubMedGoogle Scholar
• Yu IJ. Single-Wall Carbon Nanotubes (SWCNT) Induce Cytotoxicity and Genotoxicity Produced by Reactive Oxygen Species (ROS) Generation in Phytohemagglutinin (PHA)-stimulated male human peripheral blood lymphocytes AU - Kim, Jin Sik. J Toxicol Environ Health A. 2014;77(19):1141–1153. doi:10.1080/15287394.2014.91706225119736
   PubMedGoogle Scholar
• Pichardo S, Gutiérrez-Praena D, Puerto M, et al. Oxidative stress responses to carboxylic acid functionalized single wall carbon nanotubes on the human intestinal cell line Caco-2. Toxicol In Vitro. 2012;26(5):672–677. doi:10.1016/j.tiv.2012.03.00722449549
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Jiang LI, Kitaura R, Shinohara H. Minimal inflammogenicity of pristine single-wall carbon nanotubes. Nagoya J Med Sci. 2015;77(1–2):195–202.25797984
   PubMed Web of Science ®Google Scholar
• Syama S, Mohanan PV. Safety and biocompatibility of graphene: A new generation nanomaterial for biomedical application. Int J Biol Macromol. 2016;86:546–555. doi:10.1016/j.ijbiomac.2016.01.11626851208
   PubMed Web of Science ®Google Scholar
• Ge C, Du J, Zhao L, et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci USA. 2011;108(41):16968–16973. doi:10.1073/pnas.110527010821969544
   PubMed Web of Science ®Google Scholar
• Ebrahim-Habibi MB, Ghobeh M, Mahyari FA, Rafii-Tabar H, Sasanpour P. An investigation into non-covalent functionalization of a single-walled carbon nanotube and a graphene sheet with protein G: A combined experimental and molecular dynamics study. Scientific Reports. 2019;9(1):1273.30718580
   PubMed Web of Science ®Google Scholar
• Raghavendra AJ, Fritz K, Fu S, Brown JM, Podila R, Shannahan JH. Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state. Sci Rep. 2017;7(1):8382–8390. doi:10.1038/s41598-017-08896-w28814800
   PubMedGoogle Scholar
• Du P, Zhao J, Mashayekhi H, Xing B. Adsorption of bovine serum albumin and lysozyme on functionalized carbon nanotubes. J Phys Chem C. 2014;118(38):22249–22257. doi:10.1021/jp5044943
   Web of Science ®Google Scholar
• Xie L, Lin D, Luo Y, Li H, Yang X, Wei G. Effects of hydroxylated carbon nanotubes on the aggregation of Aβ16–22 peptides: a combined simulation and experimental study. Biophys J. 2014;107(8):1930–1938. doi:10.1016/j.bpj.2014.08.03425418174
   PubMedGoogle Scholar
• Li H, Luo Y, Derreumaux P, Wei G. Carbon nanotube inhibits the formation of β-sheet-rich oligomers of the Alzheimer’s amyloid-β (16–22) peptide. Biophys J. 2011;101(9):2267–2276. doi:10.1016/j.bpj.2011.09.04622067167
   PubMed Web of Science ®Google Scholar
• Jana AK, Sengupta N. Adsorption mechanism and collapse propensities of the full-length, monomeric Aβ1–42 on the surface of a single-walled carbon nanotube: a molecular dynamics simulation study. Biophys J. 2012;102(8):1889–1896. doi:10.1016/j.bpj.2012.03.03622768945
   PubMedGoogle Scholar
• Mohammadi S, Nikkhah M, Hosseinkhani S. Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor. Int J Nanomedicine. 2017;12:8831–8840. doi:10.2147/IJN.S14476429276384
   PubMedGoogle Scholar
• Pang R, Li M, Zhang C. Degradation of phenolic compounds by laccase immobilized on carbon nanomaterials: diffusional limitation investigation. Talanta. 2015;131:38–45. doi:10.1016/j.talanta.2014.07.04525281070
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kisin ER, Murray AR, et al. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol Appl Pharmacol. 2007;221(3):339–348. doi:10.1016/j.taap.2007.03.01817482224
   PubMed Web of Science ®Google Scholar
• Singh RP, Sharma G, Sonali, et al. Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment. Colloids Surf B Biointerfaces. 141;2016:429–442. doi:10.1016/j.colsurfb.2016.02.01126895505
   PubMed Web of Science ®Google Scholar
• Ono K, Yamada M. Vitamin A potently destabilizes preformed α-synuclein fibrils in vitro: implications for Lewy body diseases. Neurobiol Dis. 2007;25(2):446–454. doi:10.1016/j.nbd.2006.10.01017169566
   PubMed Web of Science ®Google Scholar
• Yoosefian M, Jahani M. A molecular study on drug delivery system based on carbon nanotube for the novel norepinephrine prodrug, Droxidopa. J Mol Liq. 2019;15(284):258–264. doi:10.1016/j.molliq.2019.04.016
   Google Scholar
• Yoosefian M, Rahmanifar E, Etminan N. Nanocarrier for levodopa Parkinson therapeutic drug; comprehensive benserazide analysis. Artif Cells Nanomed Biotechnol. 2018;46(sup1):434–446. doi:10.1080/21691401.2018.143058329378432
   PubMed Web of Science ®Google Scholar
• Yoosefian M, Pakpour A, Etminan N. Nanofilter platform based on functionalized carbon nanotubes for adsorption and elimination of Acrolein, a toxicant in cigarette smoke. Appl Surf Sci. 2018;444:598–603. doi:10.1016/j.apsusc.2018.03.108
   Web of Science ®Google Scholar
• Yoosefian M, Etminan N. Leucine/Pd-loaded (5, 5) single-walled carbon nanotube matrix as a novel nanobiosensors for in silico detection of protein. Amino Acids. 2018;50(6):653–661. doi:10.1007/s00726-018-2552-429536267
   PubMedGoogle Scholar
• Yoosefian M. A high efficient nanostructured filter based on functionalized carbon nanotube to reduce the tobacco-specific nitrosamines, NNK. Appl Surf Sci. 2018;15(434):134–141. doi:10.1016/j.apsusc.2017.10.166
   Google Scholar
• Yoosefian M, Etminan N. The role of solvent polarity in the electronic properties, stability and reactivity trend of a tryptophane/Pd doped SWCNT novel nanobiosensor from polar protic to non-polar solvents. RSC Adv. 2016;6(69):64818–64825. doi:10.1039/C6RA14006H
   Web of Science ®Google Scholar